Vitality Unleashed: The Functional Medicine Podcast

Treating Sleep Apnea Today Can Protect Your Brain Tomorrow

• Dr. Kumar from LifeWellMD.com • Episode 198

Share episode

Send us a text

Disclaimer:
The information provided in this podcast is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making changes to your supplement regimen or health routine. Individual needs and reactions vary, so it’s important to make informed decisions with the guidance of your physician.

Connect with Us:
If you enjoyed today’s episode, be sure to subscribe, leave us a review, and share it with someone who might benefit. For more insights and updates, visit our website at Lifewellmd.com.

Stay Informed, Stay Healthy:
Remember, informed choices lead to better health. Until next time, be well and take care of yourself.

SPEAKER_01:

If you're someone who is really prioritizing your health span, your longevity, you're probably already on top of your diet, your exercise, your biomarkers.

SPEAKER_00:

For sure. You've got the data.

SPEAKER_01:

But the thing is, sometimes the biggest threats to our long-term wellness, they're not the things we measure every day. They're these silent conditions that can accelerate damage while we're not even conscious.

SPEAKER_00:

Roll we sleep.

SPEAKER_01:

Exactly. So today we're doing a deep dive into one of the most critical and frankly overlooked connections in preventative health. The really strong link between poor sleep, specifically obstructive sleep apnea, and a much higher risk for Parkinson's disease later in life.

SPEAKER_00:

Aaron Powell This is such an essential topic. We're talking about a major neurodegenerative condition, Parkinson's, and a midlife factor, sleep apnea, that is not only incredibly common, but and this is the key, it's entirely modifiable.

SPEAKER_01:

Modifiable. That's the whole point.

SPEAKER_00:

Right. So our mission here is to really distill the hard science from two huge global studies and explain what's actually happening on a biological level. And you're going to leave with a clear, actionable plan.

SPEAKER_01:

And we've got great sources. We have a massive population study from Taiwan, another gigantic analysis of U.S. veterans. This is not about just treating snoring anymore. This is about protecting your brain for the long haul.

SPEAKER_00:

Okay, so before we jump into the big data, let's just quickly define the players here so the mechanism makes sense later.

SPEAKER_01:

Good idea.

SPEAKER_00:

Obstructive sleep apnea, or OSA. It's basically when your airway repeatedly collapses while you sleep. This causes apnea, which is when you stop breathing completely, or hypopnea where breathing is just severely restricted.

SPEAKER_01:

And the key thing there is the oxygen, right?

SPEAKER_00:

Exactly. It leads to chronic intermittent oxygen deprivation. The clinical term is hypoxia, and that is a major, major stressor on the entire body.

SPEAKER_01:

And on the other side of the equation is Parkinson's disease, or PD, which is what we're all trying to prevent.

SPEAKER_00:

Right. A central nervous system disorder. It's defined by the progressive death of your dopamine-producing neurons, specifically in a part of the brain called the substantia nigra.

SPEAKER_01:

And when those dopamine cells die off, that's when you start to see the motor symptoms everyone knows. The tremor, the rigidity.

SPEAKER_00:

So the big question has always been what's speeding up that cell death? And the global evidence is sorting to point a very clear finger directly at OSA.

SPEAKER_01:

Let's start with the Taiwan cohort study. This one gives us a really clear early signal.

SPEAKER_00:

It really does.

SPEAKER_01:

Researchers ran this large long-term follow-up study. They tracked over 16,000 newly diagnosed OSA patients.

SPEAKER_00:

And they did something really smart. For every single one of those patients, they matched them with the control subject. Someone without OSA, but with the same age, gender, and other health conditions.

SPEAKER_01:

Which is so crucial, right? To isolate the effect of the sleep apnea itself.

SPEAKER_00:

It's vital. Otherwise, you don't know what you're really measuring. And what they found over about five and a half years was well, it was statistically undeniable.

SPEAKER_01:

Okay, so what were the numbers?

SPEAKER_00:

The rate of new Parkinson's cases in the OSA group was significantly higher. It was 2.3 per 1,000 person years compared to just 1.71 in the control group.

SPEAKER_01:

Okay, person years can be a bit clinical. Can you translate that comparison for us?

SPEAKER_00:

Absolutely. Don't worry about the raw numbers so much as the comparison. The real takeaway is this: after they adjusted for everything else, diabetes, high blood pressure, you name it, patients with OSA were 1.37 times more likely to develop Parkinson's.

SPEAKER_01:

So 37% more likely.

SPEAKER_00:

A 37% higher risk. It tells us OSA isn't just correlated, it's an independent player in this landscape.

SPEAKER_01:

An independent risk factor stacking the odds against you. And that study was powerful, but then its findings were just massively confirmed by a completely separate and frankly enormous analysis.

SPEAKER_00:

The U.S. veterans cohort study, I mean, this one is just on another scale. They pulled electronic health records from over 11 million US veterans.

SPEAKER_01:

11 million?

SPEAKER_00:

The scale is just unparalleled. And over about five years, they saw that almost 14% of this huge population had OSA.

SPEAKER_01:

And the sheer volume of that data, it just validates everything the Taiwan study found, doesn't it?

SPEAKER_00:

It does. They confirmed that OSA was independently associated with new cases of Parkinson's, even after they controlled for really complex things like BMI, psychiatric history, all of it. The connection was just incredibly robust.

SPEAKER_01:

So the Taiwan study gave us that relative risk, the 1.37 number. What did the veteran study add to the picture?

SPEAKER_00:

Give us a really concrete sense of the burden. They calculated that veterans with OSA had 1.61 additional cases of Parkinson's per thousand people after six years.

SPEAKER_01:

Wow. Okay, so that really quantifies the impact. If you take a thousand people with untreated sleep apnea, you can expect almost two extra cases of Parkinson's that likely wouldn't have happened otherwise.

SPEAKER_00:

That's it. It just definitively connects the dots. You have two massive diverse studies on two different continents, and they both agree. OSA is a genuine independent risk factor for developing Parkinson's disease down the road.

SPEAKER_01:

This is a huge finding. It means we have to start thinking about OSA not just as a fatigue issue, but as a direct neurological threat.

SPEAKER_00:

Exactly. And that reframing is critical for longevity.

SPEAKER_01:

Agreed. So now let's dig into where the risk is highest. Because the data isn't uniform across the population. There's actually a really fascinating bit of tension in the findings.

SPEAKER_00:

Right. So the initial studies, especially from Taiwan, they suggested the risk was really dependent on age and sex.

SPEAKER_01:

Okay.

SPEAKER_00:

They pointed to older patients, so 65 and up, and male patients as having a much higher risk. It basically painted a picture of elderly men being the most vulnerable group.

SPEAKER_01:

Aaron Powell, which sort of makes intuitive sense since Parkinson's has a higher baseline rate in older men anyway. Trevor Burrus, Jr.

SPEAKER_00:

It does, but then you add in comorbidities. The Taiwan subgroup analysis found that Parkinson's risk was even higher if the OSA patient also had things like coronary artery disease, stroke, or chronic kidney disease.

SPEAKER_01:

Aaron Powell So other issues related to vascular health and inflammation are amplifying the risk. Trevor Burrus, Jr.

SPEAKER_00:

They're throwing fuel on the fire, absolutely. Poor vascular health means your brain can't clear out toxins and waste as well. But this brings us to that tension you mentioned, the part that pushes back on the idea that it's just about older men. Trevor Burrus, Jr.

SPEAKER_01:

This is from the U.S. veterans data, right?

unknown:

Trevor Burrus, Jr.

SPEAKER_00:

Right. Because their data set was so huge, they could adjust for variables with incredible precision. And they found a critical difference. While the risk was there for everyone, the magnitude of the association, the statistical strength, was actually greater in female veterans.

SPEAKER_01:

Oh, that's interesting. So what does that mean?

SPEAKER_00:

It means that while men might have a higher absolute number of cases for a woman who has OSA, that condition disproportionately increases her individual risk more than it does for a man with OSA.

SPEAKER_01:

So we can't just fall back on simple demographics. The message isn't only older men need to worry.

SPEAKER_00:

Not at all. The message is that OSA carries a significant independent risk for everyone across the entire adult population. Everybody needs to be screened. We have to treat this as a threat to everyone's neurological future.

SPEAKER_01:

Okay, so now we get to the core of it. This is where it gets really, really interesting. We've established this strong correlation, but why? Why would a breathing condition in your throat affect your brain cells decades later? What is the actual biological mechanism?

SPEAKER_00:

Aaron Powell The simplest way to put it is that OSA basically weaponizes cellular stress. Yeah. It doesn't just disrupt your sleep, it forces your brain and your body into a state of continuous alarm every single night for years.

SPEAKER_01:

Aaron Powell And that alarm is the lack of oxygen, the chronic intermittent hypoxia.

SPEAKER_00:

Aaron Powell That's the trigger. And the body's response to that is to ramp up two really destructive processes: systemic inflammation and crucially for Parkinson's, something called oxidative stress.

SPEAKER_01:

Aaron Powell Okay. Most people get inflammation, but let's focus on oxidative stress. Aaron Powell What is that exactly and why is it so bad for these specific dopamine neurons?

SPEAKER_00:

Aaron Powell Think of oxidative stress as a kind of rapid unchecked rusting process at the cellular level. When your oxygen levels plummet and then surge back up, which is what happens every time you gasp for air, your cell's metabolic machinery just gets completely overwhelmed.

SPEAKER_01:

It's too much, too fast.

SPEAKER_00:

Way too much. And that process generates these highly reactive molecules called free radicals.

SPEAKER_01:

Which are like tiny little wrecking balls inside your cells.

SPEAKER_00:

Aaron Powell That's a great analogy. They damage everything cell membranes, proteins, even DNA. But specifically for Parkinson's, what studies show is that this chronic oxidation promotes something called alpha sinucline oligomerization.

SPEAKER_01:

Okay, that's the technical term. Alpha sinuclein is the bad actor protein in Parkinson's, right?

SPEAKER_00:

It's the key pathological protein. Everyone has alpha sinucle or alphazin in their neurons. In a healthy brain, it's fine, but in Parkinson's, it misfolds, it clumps together and forms these toxic structures.

SPEAKER_01:

And what you're saying is that the oxidative stress from the sleep apnea is the spark. It's the catalyst that causes that healthy protein to start misfolding and clumping up in the first place.

SPEAKER_00:

Precisely. The intermittent hypoxia is providing the constant biological fuel, that oxidative stress, that starts the whole cascade. You are essentially turning the oxygen alarm on and off every few minutes, all night, for years. You are accelerating the very root pathology of Parkinson's disease.

SPEAKER_01:

There's a quote from one of the researchers that just captures it perfectly. They said, if you stop breathing and oxygen is not at a normal level, your neurons are probably not functioning at a normal level either.

SPEAKER_00:

And then they add the crucial part.

SPEAKER_01:

Add that up night after night, year after year, and it may explain why fixing the problem may build in some resilience.

SPEAKER_00:

And that's the most powerful summation of this whole deep dive. Sleep apnea isn't a problem for your late 50s. It's a problem that can start damaging your brain in your 30s and 40s, quietly laying the groundwork for what's to come.

SPEAKER_01:

Which brings us to the most important section. So what does this all mean? What do we do about it?

SPEAKER_00:

Well, the most powerful insight is right there. OSA isn't just an inconvenience, it is a potentially modifiable risk factor for Parkinson's disease.

SPEAKER_01:

And this is where we have some phenomenal news. Because unlike so many other risk factors for neurodegenerative disease, we have a highly effective treatment.

SPEAKER_00:

Positive airway pressure, the CPAP machine.

SPEAKER_01:

And the study specifically looked at this, didn't they? Did treatment actually lower the risk?

SPEAKER_00:

They did. And the findings were conclusive. The risk of developing Parkinson's was significantly attenuated, meaning it was substantially reduced by treating the sleep apnea with CPAP. So it works. It really works. The veteran study showed it clearly.

SPEAKER_01:

This is the ultimate example of preventative longevity medicine in action.

SPEAKER_00:

It is. We aren't just treating a symptom like fatigue. We are literally changing a person's neurological trajectory.

SPEAKER_01:

But the key here has to be adherence, right? The CPAP only works if you actually use it every night.

SPEAKER_00:

That's everything. For someone who is truly focused on their health span, using a CPAP isn't a chore. It's a critical daily investment in your long-term brain health.

SPEAKER_01:

So if you're out there listening and you have the symptoms, chronic loud snoring, maybe your partner says you stop breathing, or you just have this crushing daytime fatigue. This data is a mandate for action.

SPEAKER_00:

Don't let a condition that can be managed with a simple machine continue to inflict this kind of cellular damage on your brain. This is exactly the kind of root cause strategy we need for superior health and longevity.

SPEAKER_01:

The evidence is just too strong now to ignore. The potential benefits slashing your risk of a debilitating neurodegenerative disease is just enormous.

SPEAKER_00:

The only thing better than living a long life is making sure that life is vibrant, mobile, and cognitively sound. And that means you have to aggressively mitigate these silent risks.

SPEAKER_01:

It really makes you wonder what other common midlife conditions are we just accepting as normal that are actually chipping away at our brain health for later life?

SPEAKER_00:

That is the million-dollar question. But for OSA, the takeaway is clear. Screen, diagnose, and treat. The science mandates that we act now.

SPEAKER_01:

And for you, the listener, if you're ready to move beyond just reacting to problems and you want to start a comprehensive, proactive wellness journey, one that addresses these deep long-term risks, we really encourage you to reach out to experts who focus on optimizing health span.

SPEAKER_00:

That proactive approach means looking at the entire picture, making sure that things like intermittent hypoxia and systemic inflammation are under control. That's what we specialize in.

SPEAKER_01:

We encourage you to reach out to Dr. Kumar and the team at LifeWellmd.com. This is the critical first step in managing your future health and securing your neurological future.

SPEAKER_00:

Take control of this modifiable risk. Call 561 210 9999 today to begin your wellness evaluation and start your journey toward optimizing your health span. Don't let sleep apnea go untreated.